These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24378323)

  • 1. MRI and PET in mouse models of myocardial infarction.
    Buonincontri G; Methner C; Carpenter TA; Hawkes RC; Sawiak SJ; Krieg T
    J Vis Exp; 2013 Dec; (82):e50806. PubMed ID: 24378323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.
    Bulluck H; White SK; Fröhlich GM; Casson SG; O'Meara C; Newton A; Nicholas J; Weale P; Wan SM; Sirker A; Moon JC; Yellon DM; Groves A; Menezes L; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):e003900. PubMed ID: 26926269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of myocardial viability in a small animal model: comparison of MRI, SPECT, and PET.
    Thomas D; Bal H; Arkles J; Horowitz J; Araujo L; Acton PD; Ferrari VA
    Magn Reson Med; 2008 Feb; 59(2):252-9. PubMed ID: 18228591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid PET/MR imaging of the heart: feasibility and initial results.
    Nensa F; Poeppel TD; Beiderwellen K; Schelhorn J; Mahabadi AA; Erbel R; Heusch P; Nassenstein K; Bockisch A; Forsting M; Schlosser T
    Radiology; 2013 Aug; 268(2):366-73. PubMed ID: 23651530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
    Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
    Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging.
    Wollenweber T; Roentgen P; Schäfer A; Schatka I; Zwadlo C; Brunkhorst T; Berding G; Bauersachs J; Bengel FM
    Circ Cardiovasc Imaging; 2014 Sep; 7(5):811-8. PubMed ID: 25049056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
    Wilk B; Wisenberg G; Dharmakumar R; Thiessen JD; Goldhawk DE; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2083-2099. PubMed ID: 31797321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial viability of a patient with old myocardial infarction by
    Masuda A; Nemoto A; Yamaki T; Oriuchi N; Takenoshita S; Takeishi Y
    J Nucl Cardiol; 2018 Aug; 25(4):1423-1426. PubMed ID: 28585030
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated FDG PET/MR Imaging for the Assessment of Myocardial Salvage in Reperfused Acute Myocardial Infarction.
    Nensa F; Poeppel T; Tezgah E; Heusch P; Nassenstein K; Mahabadi AA; Forsting M; Bockisch A; Erbel R; Heusch G; Schlosser T
    Radiology; 2015 Aug; 276(2):400-7. PubMed ID: 25848898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese-enhanced T
    Spath N; Tavares A; Gray GA; Baker AH; Lennen RJ; Alcaide-Corral CJ; Dweck MR; Newby DE; Yang PC; Jansen MA; Semple SI
    Sci Rep; 2020 Feb; 10(1):2018. PubMed ID: 32029765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation.
    Kunze KP; Dirschinger RJ; Kossmann H; Hanus F; Ibrahim T; Laugwitz KL; Schwaiger M; Rischpler C; Nekolla SG
    J Cardiovasc Magn Reson; 2018 May; 20(1):33. PubMed ID: 29792210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI.
    Higuchi T; Nekolla SG; Jankaukas A; Weber AW; Huisman MC; Reder S; Ziegler SI; Schwaiger M; Bengel FM
    J Nucl Med; 2007 Feb; 48(2):288-94. PubMed ID: 17268027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats.
    Chapon C; Jackson JS; Aboagye EO; Herlihy AH; Jones WA; Bhakoo KK
    Mol Imaging Biol; 2009; 11(1):31-8. PubMed ID: 18773246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.